Abajar, Baby Boy .
HRN: 23-34-78 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/21/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/21/2023
07/28/2023
IVTT
30
Q24
PSNB
Checking Final Appropriateness
Indication: Prophylaxis Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes